Pro-inflammatory mediators such as TNFα, IL-8 and IL-1α/β have been shown to be elevated at T1D onset; the same time at which a patient’s own serum would likely be collected for use in expanding DC [22,23]. This evidence concerns the gene IL1A and type 1 diabetes mellitus.